WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Revenue

OverviewEarningsRevenue
DividendOwnership
Pasithea Therapeutics revenue was $0.00 for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2024) ending on Sep 30, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, KTTA annual revenue was $0.0, with N/A growth year-over-year.

KTTA past revenue growth

How has KTTA's revenue growth performed historically?

Company
N/A
Industry
1,212.64%
Market
38.67%
KTTA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KTTA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

KTTA revenue history

Current Revenue
$0.0
Current Earnings
-$15.8M
Current Profit Margin
0%

Be the first to know when KTTA announces revenue.

KTTA Revenue History By Year

KTTA Yearly RevenueKTTA RevenueKTTA ChangeKTTA Revenue Growth
2023-12-31$0.00N/AN/A
2022-12-31$0.00-$15.06k-100.00%
2021-12-31$15.06kN/AN/A
2020-12-31$0.00N/AN/A

1 of 1

Pasithea Therapeutics Revenue FAQ

What was KTTA's revenue last quarter?

On Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q3 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Pasithea Therapeutics's revenue was $0.00.

What was Pasithea Therapeutics's revenue in 2023?

Pasithea Therapeutics's annual revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.

How much does Pasithea Therapeutics make in a day?

Based on Pasithea Therapeutics annual revenue for the past three years, KTTA makes an average of $13.76 per day.

What was Pasithea Therapeutics's annual revenue growth in the past year?

As of Q4 2024, Pasithea Therapeutics's revenue has grown null year over year. Pasithea Therapeutics's revenue in the past year totaled $0.00.

How much does Pasithea Therapeutics make in a year?

Pasithea Therapeutics's revenue by year for the past three years is:
  • Pasithea Therapeutics's revenue for the twelve months ending Dec 31, 2023 was $0.00, a N/A decrease year over year.
  • Pasithea Therapeutics's annual revenue for Dec 31, 2022 was $0.00, a 100% decrease from 2021.
  • Pasithea Therapeutics's annual revenue for 2021 was $15.06 thousand, a Infinity% increase from 2020.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.